Schulich school of Medicine and Dentistry logo Schulich Medicine & Dentistry Research Office

Funding

working on test tubes

Latest funding opportunities listed:

Alzheimer's Association - Part the Cloud Translational Research Funding

"In its fourth iteration, the Alzheimer's Association is pleased to announce the Part the Cloud Translational Research Funding initiative to increase the research efforts in Phase I and Phase II (Proof of Concept) clinical trials directed towards Alzheimer’s disease and related dementias in North America."

Deadline for Letter of Intent: July 15, 2015

Read More

Arnold P. Gold Research Institute

The Arnold P. Gold Foundation Research Institute’s mission is to discover and disseminate knowledge about humanism in healthcare to improve health and the human condition.

Deadline for Letter of Intent for Research Grant Requests of $5,001-$30,000: August 1; February 1

Read More

Association for Frontotemporal Degeneration - Pilot Grants

AFTD Pilot Grants are intended to support early career investigators and to provide seed funds for new and creative ideas that address critical issues in FTD research. Funded investigators are encouraged to use the preliminary data generated in a pilot grant toward larger public or private grant applications that will further our understanding of the FTD disorders.

Deadline: July 31, 2015

Read More

Association for International Cancer Research

AICR awards grants to support fundamental or translational research into the causes, mechanisms, diagnosis, treatment and prevention of cancer. AICR does not support clinical research. AICR will consider applications that include some clinical research in a project which is mostly basic or translational. However, completely clinical applications, such as intervention studies, clinical trials or health care delivery research are beyond the remit of AICR.

Deadline: October 1, 2015

Read More

BrightFocus Foundation - Macular Degeneration Research

The funding mechanisms are designed to provide initial funding for highly innovative experimental ideas.

Deadline for Letter of Intent: July 15, 2015

Read More

Canadian Cancer Society Research Institute - Innovation Grants

Innovation grants have been created to support innovative, creative problem solving in cancer research. As competition for grant funding increases, peer review panels become more conservative and risk averse, emphasizing feasibility more than innovation. The goal of this CCSRI grant program is to support unconventional concepts, approaches or methodologies to address problems in cancer research. Innovation projects will include elements of creativity, curiosity, investigation, exploration and opportunity. Successful projects may be based on "high risk" ideas, but will have the potential for "high reward" (i.e. to significantly impact the understanding of cancer and generate new approaches to combat the disease by introducing novel ideas into use or practice).

Deadlines for Abstract Submission: August 15, 2015; February 15, 2016
Deadlines for Application: October 01, 2015; April 01, 2016

Read More

Citizens United for Research in Epilepsy (CURE)

The award supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to epilepsy.

Deadline for letter of intent: July 15, 2015

Read More

Early Researcher Awards

The Early Researcher Awards program gives funding to new researchers working at publicly funded Ontario research institutions to build a research team.

Deadline: August 24, 2015

Read More

Frick Foundation for Research on ALS

The goal of the foundation is to provide research grants for the study of the understanding of the basic causes of amyotrophic lateral sclerosis (ALS). These awards are not directed to clinically related projects for patient care.

Deadline: Sept 30, 2015

Read More

Genome Canada - Disruptive Innovation in Genomics

"This funding opportunity will be aimed at supporting projects focused on the development of disruptive innovation in the field of genomics, which for the purpose of this competition is defined as a new genomics-based technology or the application of an existing technology from another field, applied to the field of genomics, that is truly transformative in that it has the potential to either displace an existing technology, disrupt an existing market or create a new market. A disruptive innovation offers the capability to do things not previously possible and is not an incremental improvement of an existing technology. Ontario applicants will be required to apply for funding through the Ontario Genomics Institute (OGI). "

Deadline for registration: September 4, 2015

Read More

Genzyme Corporation - Investigator-Sponsored Studies

"Genzyme's ISS program supports research that can advance scientific, medical, health economic, and other knowledge about its existing marketed products and diseases it study. Results of such studies may lead to greater understanding of our therapies and their potential applications, may improve patient care, and spark new ideas for further disease-related research. Researchers may propose the following types of studies for evaluation: Prospective and retrospective clinical studies with approved Genzyme drugs or devices; Observational studies, such as epidemiological research on diseases Genzyme treats; Health outcomes research, especially related to diseases Genzyme treats; In vitro and animal studies with Genzyme drugs or devices. "

Deadline: Continuous

Read More

Glaucoma Research Foundation Shaffer Grants

Shaffer Grants are 1-year grants awarded in the amount of $40,000.

Deadline for preliminary proposals: July 31, 2015

Read More

GRAMMY Foundation Grant Program

The GRAMMY Foundation Grant Program awards grants to organizations and individuals to support research on the impact of music on the human condition. Examples might include the study of the effects of music on mood, cognition and healing, as well as the medical and occupational well-being of music professionals and the creative process underlying music. Priority is given to projects with strong methodological design as well those addressing an important research question.

Deadline: October 1, 2015

Read More

ITI International Team for Implantology Research Grant Program

The ITI Foundation supports preclinical and clinical research in implant dentistry.

Annual Deadlines: Feb 27; Aug 31

Read More

Juvenile Diabetes Research Foundation International: Innovative Grants

JDRF provides seed funding for highly innovative research with potential significant impact on accelerating the mission of JDRF. The innovative research should have the potential for a change in the current paradigm or conventional wisdom or to lead to a seminal discovery or to be groundbreaking. Preliminary data is not required in the proposal but the underlying premise, goal, or hypothesis must be plausible and the proposal must be focused with a well-defined goal.

Deadline: July 30, 2015

Read More

Kidney Foundation of Canada - Biomedical Research Grants

Biomedical Research Grants provide financial support to medical researchers to assist in defraying the operating costs of research, which may include the purchase of materials, supplies and equipment and the payment of laboratory assistants.

"Deadline for Registration: September 1, 2015 Deadline for Full Application: October 1, 2015"

Read More

Leona M. and Harry B. Helmsley Charitable Trust Breakthrough Initiative

The Helmsley Breakthrough Initiative (HBI) of The Leona M. and Harry B. Helmsley Charitable Trust is an initiative that supports early-stage studies and pilot projects in the field of type 1 diabetes (T1D) that have a strong rationale but little or no preliminary data.

Deadline for expression of interest submission: August 3, 2015

Read More

Lymphoma Research Foundation Grant Program

In calendar year 2015, LRF is offering the three Young Investigator Grant programs, as well as a Disease Focus Area grant in follicular lymphoma.

Deadline: September 2, 2015

Read More

Michael J. Fox Foundation for Parkinson's Research Improved Biomarkers and Clinical Outcome Measures Program

The Michael J. Fox Foundation seeks to support research that will develop improved biomarker tools and clinical outcome measures to assist in clinical trial design, execution and interpretation of results. Funding will be awarded to projects that improve the ability to enrich subject populations in clinical trials and/or determine whether experimental treatments are modifying the course of the disease, its symptoms or its progression. MJFF is also interested in supporting projects to determine target engagement/modulation and pharmacodynamic response, especially for high-priority therapeutic targets like alpha-synuclein, LRRK2, parkin and glucocerebrosidase.

Deadline for Pre-Proposals: October 28, 2015

Read More

Michael J. Fox Foundation for Parkinson's Research Target Advancement Program

The Michael J. Fox Foundation believes that a major hurdle in the development of promising treatments for Parkinson's disease is the lack of well-validated targets linked to the disease process. By promoting critical target validation studies within academic and industry laboratories, MJFF investments can de-risk subsequent drug development and ultimately accelerate the creation of innovative therapies for Parkinson's patients. Part of our Edmond J. Safra Core Programs for PD Research, the Target Advancement program seeks to build robust evidence to rationalize biological pathways and targets for further translation into new Parkinson's treatments.

Deadline for Pre-proposals: October 28, 2015

Read More

Michael J. Fox Foundation for Parkinson's Research Therapeutic Pipeline Program

The Michael J. Fox Foundation for Parkinson's Research (MJFF) seeks to stimulate development of Parkinson's disease (PD) therapeutics with potential for fundamentally altering disease course and/or significantly improving treatment of symptoms above and beyond current standards of care. Part of the annual Edmond J. Safra Core Programs for PD Research, the Therapeutic Pipeline Program is open to industry and academic investigators working at either pre-clinical or clinical stages of drug and therapeutic development. Proposals must focus on a treatment strategy with clear potential for PD and have a well-defined plan for moving toward clinical utility for patients. Both novel approaches as well as repositioning of approved or clinically safe therapies from other non-PD indications are of interest.

Deadline for Pre-Proposals: October 28, 2015

Read More

MSSRF Gut Microbiome Project

The MS Scientific Research Foundation is pleased to launch a request for applications (RFA) to invite Canadian and international academic investigators to apply for funding to specifically study the gut microbiome in collaboration with a larger, multi-site pediatric MS study.

Deadline: August 7, 2015 at 16:00 EDT

Read More

Multiple Sclerosis Society of Canada

"The Operating Grant Program is intended to support research in multiple sclerosis (MS). The MS Society welcomes applications that are fundamental as well as applied studies, nonclinical or clinical in nature, including projects in patient management, care and rehabilitation. There are two streams of research: (1) biomedical and clinical, and (2) population health. "

Deadline: October 1, 2015

Read More

Musculoskeletal Transplant Foundation

"The objective of the proposed research is to advance allografts, the science of transplantation and the biological reconstruction of musculoskeletal tissues. Grants include Junior Investigator Grants and Established Investigator Grants. "

Deadline: September 1, 2015

Read More

Musculoskeletal Transplant Foundation Research Grant

The Orthopaedic Research and Education Foundation in partnership with the Musculoskeletal Transplant Foundation (MTF) offers seed money for new investigators conducting research on biologic skeletal reconstruction, including implants and stem cells. Research may be basic or clinical. Clinical relevance must be clearly noted in the abstract and specific aims and be obvious from the title and study design. PI or Co-PI must be an orthopaedic surgeon. PhDs and DVMs are eligible if affiliated with an orthopaedic department and working with an orthopaedic surgeon.

Deadline: September 2, 2015

Read More

NARSAD Distinguished Investigator Grant

The NARSAD Distinguished Investigator Grant provides support for experienced investigators (full professor or equivalent) conducting neurobiological and behavioral research. A one-year grant of $100,000 is provided for established scientists pursuing innovative projects in diverse areas of neurobiological research. Areas of particular interest to the Scientific Council's Selection Committee include patient populations with unique or unusual characteristics and central nervous system developments.

Deadline: July 6, 2015

Read More

Orthopaedic Research and Education Foundation

Advances the scientific training of the next orthopaedic surgeons by providing seed and start-up funding for promising research projects.

Deadline: September 2, 2015

Read More

Research Fund for Post-Poliomyelitis and Neuromuscular Respiratory Research

"The Research Fund offers two grants:

  • The Thomas Wallace Rogers Memorial Respiratory Research Grant to study the management of neuromuscular respiratory insufficiency and to explore historical, social, psychological and independent living aspects of long-term home mechanical ventilation
  • The Post-Poliomyelitis Research Grant to study the cause(s), treatment and management of the late effects of polio and to explore historical, social, psychological and independent living aspects of living with polio.

"

Deadline:October 1, 2015

Read More

Scleroderma Foundation Research Grant Funding Program

The Scleroderma Foundation wants to foster development of innovative, high-quality research by new and established investigators in fields related to systemic sclerosis (SSc, scleroderma). To accomplish this goal, we offer two distinct research grants: Scleroderma Foundation New Investigator Grant, and the Scleroderma Foundation Established Investigator Grant.

Deadline: Sept 15, 2015

Read More

Vasculitis Foundation Research Program

"The purpose of the Vasculitis Foundation Research Program is to provide one- or two-year seed grants to support pilot studies in researching:
- Etiology/Pathogenesis (could include a broad range of studies of immunity, inflammation, or vascular biology. Relevance to human vasculitis will be taken into account by the reviewers.)
- Epidemiology, including genetics.
- Diagnosis, including identification of disease subtypes.
- Treatment/Management, including therapeutics to treat vasculitis or prevent complications, biomarkers, and psychosocial outcomes. "

Deadline: August 3, 2015

Read More

Wellcome Trust - Translation Fund

The aim of Translation Awards is to develop innovative and ground breaking new technologies in the biomedical area. Projects must have already demonstrated proof of principle, supported by experimental data. Applications should bridge the funding gap in commercialisation of new technologies in the biomedical area and must plan to take the product, technology or intervention to a stage at which it is sufficiently developed to be attractive to another party.

Deadline for Concept Paper: October 24, 2014

Read More

Weston Brain Institute - Early Phase Clinical Trials 2015

"To provide funding for Phase I and II clinical trials to accelerate the development of therapeutics for neurodegenerative diseases of aging "

Deadline for Letter of Intent: September 1, 2015

Read More

Western researchers can consult Pivot, a comprehensive database of grant information.

Western's Office of Research Development & Services maintains information on Funding and Opportunities.